Verapamil decreases accumulation of 99tcm-mibi and 99tcm-tetrofosmin in human breast cancer and soft tissue sarcoma cell lines

Nuclear Medicine Communications

Volumn 22, Issue 6, 2001, Pages 645-650

  Rodrigues, M ^a   Kalinowska, W ^a   Zielinski, C ^a   Sinzinger, H ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

99Tcm MIBI; 99Tcm Tetrofosmin; Breast cancer; Sarcoma; Verapamil

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; VERAPAMIL;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL VIABILITY; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ANTAGONISM; HUMAN; HUMAN CELL; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SOFT TISSUE SARCOMA;

ADENOCARCINOMA; BREAST NEOPLASMS; CALCIUM CHANNEL BLOCKERS; CELL LINE; CELL SURVIVAL; FEMALE; HUMANS; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SARCOMA; SOFT TISSUE NEOPLASMS; TECHNETIUM TC 99M SESTAMIBI; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0034992522     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200106000-00007     Document Type: Review

References (13)

1. Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994; 35: 510-515.
2. Tunggal JK, Melo T, Ballinger JR, Tannock IF. The influence of expression of P-glycoprotein on the penetration of anticancer drugs through multicellular layers. Int J Cancer 2000; 86: 101-107.
3. m-sestamibi scanning with SDZ PSC 833 as a functional detection method for resistance modulation in patients with solid tumors. Anticancer Res 1999; 19: 2349-2353.
4. Ballinger JR, Bannerman J, Boxen I, Firby P, Hartman NG, Moore MJ. Technetium-99m-tetrofosmin as a substrate for P-glycoprotein: in vitro studies in multidrug-resistant breast tumor cells. J Nucl Med 1996; 37: 1578-1582.
5. m-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistance: in vitro and in vivo studies in a rat breast tumour cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995; 16: 253-257.
6. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53: 977-984.
7. m-tetrofosmin into malignant versus nonmalignant breast cell lines. J Nucl Med 2000; 41: 1495-1499.
8. m-tetrofosmin and 99Tcm-furifosmin uptake in human soft tissue sarcoma cell lines. Eur J Nucl Med 2000; 27: 1839-1843.
9. m-Q12 into human breast cancer cell lines. Eur J Nucl Med 1996; 23: 1361-1366.
10. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 in tumor cell lines. J Nucl Med 1996; 37: 1551-1556.
11. Stein U, Shoemaker RH, Schlag PM. MDR 1 gene expression: evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas. Eur J Cancer 1996; 32A: 86-92.
12. Del Vecchio S, Ciarmiello A, Potena MI et al. in vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. Eur J Nucl Med 1997; 24: 150-159.
13. Schneider E, Yamazaki H, Sinha BK, Cowan KH. Chemosensitization of drug-sensitive and -resistant human breast cancer MCF-7 cells expressing the multidrug resistance-associated protein (MRP). Proc Am Assoc Cancer Res 1994; 35: 359.-